Medical Informatics: a bridge between two worlds
With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve the correct diagnosis […]
With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve the correct diagnosis […]
With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the […]
Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings […]
Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The […]
Digital transformation is taking root in every major industry, and healthcare and life sciences are no exception. In fact, digital technology may prove to be […]
The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. But primary […]
The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s integrated health research system was able to […]
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does […]
Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change. With drawn-out […]
As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect […]
Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become exponentially more clinically targeted and sophisticated over […]
Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, of course, lays in making medical research […]
This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for […]
This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for […]
This content is password protected. To view it please enter your password below: Password: The post Protected: Customer engagement and pharma’s field force future appeared […]
Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development […]
Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 […]
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure […]
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability […]
The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new […]
Copyright © 2024 | WordPress Theme by MH Themes